Paper26324116
The march toward malaria vaccines.
Hoffman SL and 3 others. Vaccine, 2015. Cited by 88 papers, by iCite.
Cite this record
ConductScience Library. The march toward malaria vaccines. Papers, record 26324116. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26324116
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Malaria Vaccines | Major topic |
| Malaria, Falciparum | Major topic |
| Malaria, Vivax | Major topic |
| Animals | |
| Clinical Trials, Phase III as Topic | |
| Disease Eradication | |
| Humans | |
| Immunity, Cellular | |
| Life Cycle Stages | |
| Plasmodium falciparum | |
| Plasmodium vivax | |
| Recombinant Proteins | |
| Sporozoites |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Z99 AI999999 | Intramural NIH HHS | United States | Z99AI999999 | PubMed | NIH RePORTER |
| ZIAAI001007 | NIH | NIH RePORTER | |||
| ZIAAI001009 | NIH | NIH RePORTER | |||
| ZIAAI001056 | NIH | NIH RePORTER | |||
| ZIAAI001170 | NIH | NIH RePORTER |
References107
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23136909 | A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. | N Engl J Med | 2012 | https://conductscience.org/library/papers/23136909 | PubMed |
| 2 | 15100299 | Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein. | J Immunol | 2004 | https://conductscience.org/library/papers/15100299 | PubMed |
| 3 | 15837212 | Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. | Vaccine | 2005 | https://conductscience.org/library/papers/15837212 | PubMed |
| 4 | 23613845 | The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection. | PLoS One | 2013 | https://conductscience.org/library/papers/23613845 | PubMed |
| 5 | 7685119 | Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/7685119 | PubMed |
| 6 | 26245196 | Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates. | Malar J | 2015 | https://conductscience.org/library/papers/26245196 | PubMed |
| 7 | 25012228 | A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine. | BMC Med | 2014 | https://conductscience.org/library/papers/25012228 | PubMed |
| 8 | 24509910 | Two Plasmodium 6-Cys family-related proteins have distinct and critical roles in liver-stage development. | FASEB J | 2014 | https://conductscience.org/library/papers/24509910 | PubMed |
| 9 | 9423839 | Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice. | Infect Immun | 1998 | https://conductscience.org/library/papers/9423839 | PubMed |
| 10 | 19569965 | Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. | J Infect Dis | 2009 | https://conductscience.org/library/papers/19569965 | PubMed |
| 11 | 25072396 | Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. | PLoS Med | 2014 | https://conductscience.org/library/papers/25072396 | PubMed |
| 12 | 17908809 | Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge. | Infect Immun | 2007 | https://conductscience.org/library/papers/17908809 | PubMed |
| 13 | 11930326 | Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. | J Infect Dis | 2002 | https://conductscience.org/library/papers/11930326 | PubMed |
| 14 | 22007715 | First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. | N Engl J Med | 2011 | https://conductscience.org/library/papers/22007715 | PubMed |
| 15 | 11170991 | Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. | J Infect Dis | 2001 | https://conductscience.org/library/papers/11170991 | PubMed |
| 16 | 18612426 | Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. | PLoS One | 2008 | https://conductscience.org/library/papers/18612426 | PubMed |
| 17 | 17931153 | GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives. | Expert Rev Vaccines | 2007 | https://conductscience.org/library/papers/17931153 | PubMed |
| 18 | 22496772 | Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses. | PLoS One | 2012 | https://conductscience.org/library/papers/22496772 | PubMed |
| 19 | 21262960 | The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host. | J Exp Med | 2011 | https://conductscience.org/library/papers/21262960 | PubMed |
| 20 | 18478103 | Heterologous protein expression is enhanced by harmonizing the codon usage frequencies of the target gene with those of the expression host. | PLoS One | 2008 | https://conductscience.org/library/papers/18478103 | PubMed |
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41909811 | Population HLA coverage of experimentally characterized P. falciparum CD8 + T cell epitopes as potential components of a multi-epitope malaria vaccine construct: an in silico insight. | Front Bioinform | 2026 | https://conductscience.org/library/papers/41909811 | PubMed |
| 41057897 | Costs, delivery strategies and implementation challenges for malaria vaccines: a rapid review of literature. | Trop Dis Travel Med Vaccines | 2025 | https://conductscience.org/library/papers/41057897 | PubMed |
| 40563989 | Malaria Vaccines and Global Equity: A Scoping Review of Current Progress and Future Directions. | Biomedicines | 2025 | https://conductscience.org/library/papers/40563989 | PubMed |
| 40191019 | Current Developments in Malaria Vaccination: A Concise Review on Implementation, Challenges, and Future Directions. | Clin Pharmacol | 2025 | https://conductscience.org/library/papers/40191019 | PubMed |
| 38702775 | Statistical design and analysis of controlled human malaria infection trials. | Malar J | 2024 | https://conductscience.org/library/papers/38702775 | PubMed |
| 38319556 | Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium Falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials. | Infection | 2024 | https://conductscience.org/library/papers/38319556 | PubMed |
| 37525687 | [Vaccination against malaria]. | Med Trop Sante Int | 2023 | https://conductscience.org/library/papers/37525687 | PubMed |
| 37198702 | Malaria vaccines: the 60-year journey of hope and final success-lessons learned and future prospects. | Trop Med Health | 2023 | https://conductscience.org/library/papers/37198702 | PubMed |
| 36975676 | Natural Polymeric Composites Derived from Animals, Plants, and Microbes for Vaccine Delivery and Adjuvant Applications: A Review. | Gels | 2023 | https://conductscience.org/library/papers/36975676 | PubMed |
| 36558821 | Cryopreservation of Plasmodium Sporozoites. | Pathogens | 2022 | https://conductscience.org/library/papers/36558821 | PubMed |
| 36333225 | Non-standard viral genome-derived RNA activates TLR3 and type I IFN signaling to induce cDC1-dependent CD8+ T-cell responses during vaccination in mice. | Vaccine | 2022 | https://conductscience.org/library/papers/36333225 | PubMed |
| 35999221 | A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection. | NPJ Vaccines | 2022 | https://conductscience.org/library/papers/35999221 | PubMed |
| 35706028 | A reverse vaccinology approach on transmembrane carbonic anhydrases from Plasmodium species as vaccine candidates for malaria prevention. | Malar J | 2022 | https://conductscience.org/library/papers/35706028 | PubMed |
| 35697668 | Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa. | Nat Commun | 2022 | https://conductscience.org/library/papers/35697668 | PubMed |
| 35672852 | Systems biology of malaria explored with nonhuman primates. | Malar J | 2022 | https://conductscience.org/library/papers/35672852 | PubMed |
| 35488142 | Plants as Sources of Natural and Recombinant Antimalaria Agents. | Mol Biotechnol | 2022 | https://conductscience.org/library/papers/35488142 | PubMed |
| 35357277 | Current status of experimental models for the study of malaria. | Parasitology | 2022 | https://conductscience.org/library/papers/35357277 | PubMed |
| 35060479 | Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case-control study. | Elife | 2022 | https://conductscience.org/library/papers/35060479 | PubMed |
| 34801112 | Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial. | Lancet Infect Dis | 2022 | https://conductscience.org/library/papers/34801112 | PubMed |
| 34696180 | Plasmodium falciparum Malaria Vaccines and Vaccine Adjuvants. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34696180 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CSF2 | 1437 | PubTator's text mining | https://conductscience.org/library/genes/1437 | NCBI Gene |
| CXADRP1 | 653108 | PubTator's text mining | https://conductscience.org/library/genes/653108 | NCBI Gene |
| DNAJC5 | 80331 | PubTator's text mining | https://conductscience.org/library/genes/80331 | NCBI Gene |
| ELK4 | 2005 | PubTator's text mining | https://conductscience.org/library/genes/2005 | NCBI Gene |
| HLA-C | 3107 | PubTator's text mining | https://conductscience.org/library/genes/3107 | NCBI Gene |
| NANP | 140838 | PubTator's text mining | https://conductscience.org/library/genes/140838 | NCBI Gene |
| NFKB2 | 4791 | PubTator's text mining | https://conductscience.org/library/genes/4791 | NCBI Gene |
| NT5C3A | 51251 | PubTator's text mining | https://conductscience.org/library/genes/51251 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26324116
GET https://conductscience.org/api/papers/v1/26324116/references?page=2